Hyperhomocysteinemia 94 published articles and ppts

Hyperhomocysteinemia or hyperhomocysteinaemia is a medical condition characterized by an abnormally high level of homocysteine in the blood.

Homocysteine At The Crossroads: Vitamin Status and Disease Prevention
Dr. Samuel N. Grief, MD, FCFP
http://www.uic.edu/

ACE Genotype, CAD and Restenosis After Coronary Stenting
http://www.genetics.wayne.edu

Folate and Vitamin B12 Deficiency
Sally P. Stabler, M.D.
http://www.healthyaging.pitt.edu

Risk Factors for Premature Atherosclerotic Heart Disease
http://www.uams.edu/

Diagnosis and Effect of Folate and Vitamin B12 Deficiency
Leigh Ann Martin
http://www.uky.edu

Hematology Grand Rounds
Leslie Andritsos, M.D.
http://hematology.im.wustl.edu

Systems Biomedicine and Human Disease: A New Approach to Pathobiology and Therapeutics
Joseph Loscalzo
http://www.vcu.edu

Pathogenesis of VT
http://www9.georgetown.edu

LABORATORY DIAGNOSIS OF PROTHROMBOTIC STATES
http://www.ps2004.hs.columbia.edu

Thrombophilias
Sharon Sams
http://www.pathinformatics.com


Peripheral Vascular Disease: A Vascular Surgeon’s Point of View
DANIEL S. RUSH, M.D.
http://www.etsu.edu/com

Coagulation
Keri Brophy-Martinez
http://www.austincc.edu

Ppulmonary thromboembolic disease
http://www.med.umich.edu

Stroke Epidemiology-2001
Aurora K. Pajeau, M.D., MPH
http://www.pitt.edu

Alteration in Cardiac Perfusion and Output – Part 1
Rose Bianchi, RN, DNSc.
http://online.santarosa.edu

Blood Vessels
Frank A. Acevedo, PA-C
http://iris.nyit.edu/

Hypercoagulable States Basic Clinician Training
http://www.medicine.wisc.edu

94 Published articles on Hyperhomocysteinemia

1. A Cross-Sectional Study to Detect the Prevalence of Hyperhomocysteinemia in Cases of Deep Vein Thrombosis
2. A young man with deep vein thrombosis, hyperhomocysteinemia and cobalamin deficiency
3. Acid Sphingomyelinase Gene Deficiency Ameliorates the Hyperhomocysteinemia-Induced Glomerular Injury in Mice
4. Acute myocardial infarction and pulmonary embolism in a young man with pernicious anemia-induced severe hyperhomocysteinemia
5. Age-related changes in visual function in cystathionine-beta-synthase mutant mice, a model of hyperhomocysteinemia
6. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis
7. Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia
8. Association of hyperhomocysteinemia to alcohol withdrawal in chronic alcoholics
9. B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice
10. Cardiac Dys-Synchronization and Arrhythmia in Hyperhomocysteinemia
11. Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia
12. Chronic diet-induced hyperhomocysteinemia impairs eNOS regulation in mouse mesenteric arteries
13. Chronic Hyperhomocysteinemia Causes Vascular Remodeling by Instigating Vein Phenotype in Artery
14. Cobalamin deficiency, hyperhomocysteinemia, and dementia
15. Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia
16. Cystathionine β-Synthase p.S466L Mutation Causes Hyperhomocysteinemia in Mice
17. Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-κβ in hyperhomocysteinemia
18. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.
19. Diabetes Accelerates Retinal Neuronal Cell Death In A Mouse Model of Endogenous Hyperhomocysteinemia
20. Dietary intake of S-(α-carboxybutyl)-DL-homocysteine induces hyperhomocysteinemia in rats
21. Differential effects of nutritional folic acid deficiency and moderate hyperhomocysteinemia on aortic plaque formation and genome-wide DNA methylation in vascular tissue from ApoE-/- mice
22. Effect of Folic Acid on Hematological Changes in Methionine-Induced Hyperhomocysteinemia in Rats
23. Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance
24. Effects of Hyperhomocysteinemia on Arterial Pressure and Nitric Oxide Production in Pregnant Rats
25. Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia
26. Epithelial-to-Mesenchymal Transition in Podocytes Mediated by Activation of NADPH Oxidase in Hyperhomocysteinemia
27. Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh
28. Folate Deficiency, Hyperhomocysteinemia, Low Urinary Creatinine, and Hypomethylation of Leukocyte DNA Are Risk Factors for Arsenic-Induced Skin Lesions
29. Formate can differentiate between hyperhomocysteinemia due to impaired remethylation and impaired transsulfuration
30. Genetic determinants of hyperhomocysteinemia in atherosclerosis
31. H₂S Biogenesis by Human Cystathionine γ-Lyase Leads to the Novel Sulfur Metabolites Lanthionine and Homolanthionine and Is Responsive to the Grade of Hyperhomocysteinemia
32. Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature
33. Hepatocyte Proliferation During Liver Regeneration Is Impaired in Mice with Methionine Diet-Induced Hyperhomocysteinemia
34. High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway
35. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure
36. Hyperhomocysteinemia and cardiovascular disease: The nutritional perspectives
37. Hyperhomocysteinemia and Endothelial Dysfunction
38. Hyperhomocysteinemia and function of the endoplasmic reticulum
39. Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting
40. Hyperhomocysteinemia and recurrent carotid stenosis
41. Hyperhomocysteinemia and the role of B vitamins in cancer
42. Hyperhomocysteinemia decreases bone blood flow
43. Hyperhomocysteinemia Due to Methionine Synthase Deficiency, cblG: Structure of the MTR Gene, Genotype Diversity, and Recognition of a Common Mutation, P1173L
44. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model
45. Hyperhomocysteinemia exacerbates the development of intimal hyperplasia in Sprague-Dawley rats: Alleviation by rosiglitazone
46. Hyperhomocysteinemia from trimethylation of hepatic phosphatidylethanolamine during cholesterol cholelithogenesis in inbred mice
47. Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor–mediated vasorelaxation in transgenic cystathionine beta synthase–deficient mice
48. Hyperhomocysteinemia in HIV-Infected Individuals: Correlation of a Frequent Prothrombotic Factor with CD4+ Cell Count
49. Hyperhomocysteinemia in women with unexplained sterility or recurrent early pregnancy loss from Southern Italy: a preliminary report
50. Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions
51. Hyperhomocysteinemia Increases β-Amyloid by Enhancing Expression of γ-Secretase and Phosphorylation of Amyloid Precursor Protein in Rat Brain
52. Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice
53. Hyperhomocysteinemia is a risk factor for colorectal adenoma in women
54. Hyperhomocysteinemia is Associated with Aortic Atheroma Progression in Stroke/TIA Patients
55. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study
56. Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine β-synthase deficient mice
57. Hyperhomocysteinemia, Folateo and B12 Vitamin in Iranian Patients with Acute Ischemic Stroke
58. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion.
59. Hyperhomocysteinemia: An emerging risk factor for cardiovascular disease
60. Hyperhomocysteinemia: DNA hypomethylation and endothelial degeneration
61. Impaired Nitric Oxide-Mediated Flow-Induced Coronary Dilation in Hyperhomocysteinemia : Morphological and Functional Evidence for Increased Peroxynitrite Formation
62. Increased endothelin-1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia
63. Inhibition of betaine-homocysteine S-methyltransferase in rats causes hyperhomocysteinemia and reduces liver cystathionine β-synthase activity and methylation capacity
64. Inhibition of Hepatic Glycogen Synthesis by Hyperhomocysteinemia Mediated by TRB3
65. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations.
66. Is Hyperhomocysteinemia an Alzheimer’s disease (AD) risk factor, an AD marker or neither?
67. Is hyperhomocysteinemia relevant in patients with celiac disease?
68. Mechanisms of Cardiovascular Remodeling in Hyperhomocysteinemia
69. Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
70. Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia
71. Mitochondrial Mechanism of Microvascular Endothelial Cells Apoptosis in Hyperhomocysteinemia
72. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.
73. Mouse models of cystathionine β-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia
74. Murine Models of Hyperhomocysteinemia and their Vascular Phenotypes
75. Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer's disease
76. Overexpression of Dimethylarginine Dimethylaminohydrolase Protects against Cerebral Vascular Effects of Hyperhomocysteinemia 
77. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia
78. Possible Treatment Concepts for the Levodopa-Related Hyperhomocysteinemia
79. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events
80. Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of gp91^phox gene
81. Pulmonary thromboembolism due to severe hyperhomocysteinemia associated with a methyltetrahydrofolate reductase mutation
82. Remodeling in vein expresses arterial phenotype in hyperhomocysteinemia
83. Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1
84. Status of B-Vitamins and Homocysteine in Diabetic Retinopathy: Association with Vitamin-B12 Deficiency and Hyperhomocysteinemia
85. Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol
86. The effect of aqueous extract of Embelia ribes Burm on serum homocysteine, lipids and oxidative enzymes in methionine induced hyperhomocysteinemia
87. The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet
88. The Nutrigenetics of Hyperhomocysteinemia: QUANTITATIVE PROTEOMICS REVEALS DIFFERENCES IN THE METHIONINE CYCLE ENZYMES OF GENE-INDUCED VERSUS DIET-INDUCED HYPERHOMOCYSTEINEMIA
89. The possible role of hyperhomocysteinemia on IVF outcome
90. The Treatment of Hyperhomocysteinemia
91. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia.
92. Thrombophilia in hyperhomocysteinemia
93. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia
94. Transient Increase in Homocysteine but Not Hyperhomocysteinemia during Acute Exercise at Different Intensities in Sedentary Individuals